These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37882050)

  • 1. Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool.
    Kapler S; Adery L; Hoftman GD; Amir CM; Grigoryan V; Cooper ZD; Bearden CE
    Psychol Med; 2024 Jan; 54(2):245-255. PubMed ID: 37882050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Cannabis Use in People with Psychosis.
    Chesney E; Lawn W; McGuire P
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):49-58. PubMed ID: 37971872
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis.
    Mason O; Morgan CJ; Dhiman SK; Patel A; Parti N; Patel A; Curran HV
    Psychol Med; 2009 Jun; 39(6):951-6. PubMed ID: 19017430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis.
    van der Meer FJ; Velthorst E; Meijer CJ; Machielsen MW; de Haan L
    Curr Pharm Des; 2012; 18(32):5036-44. PubMed ID: 22716158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence.
    Mokrysz C; Shaban NDC; Freeman TP; Lawn W; Pope RA; Hindocha C; Freeman A; Wall MB; Bloomfield MAP; Morgan CJA; Nutt DJ; Curran HV
    Psychol Med; 2021 Sep; 51(12):2134-2142. PubMed ID: 32340632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and Psychosis.
    West ML; Sharif S
    Child Adolesc Psychiatr Clin N Am; 2023 Jan; 32(1):69-83. PubMed ID: 36410907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Motivational interviewing for cannabis users with psychotic disorders].
    Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
    Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
    Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
    Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis consumption and psychosis or schizophrenia development.
    Ortiz-Medina MB; Perea M; Torales J; Ventriglio A; Vitrani G; Aguilar L; Roncero C
    Int J Soc Psychiatry; 2018 Nov; 64(7):690-704. PubMed ID: 30442059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls.
    Sami M; Quattrone D; Ferraro L; Tripoli G; Cascia E; Gayer-Anderson C; Selten JP; Arango C; Bernardo M; Tarricone I; Tortelli A; Gatto G; Del Peschio S; Del-Ben CM; Rutten BP; Jones PB; van Os J; de Haan L; Morgan C; Lewis C; Bhattacharyya S; Freeman TP; Lynskey M; Murray RM; Forti MD
    Psychol Med; 2021 Sep; 51(12):2074-2082. PubMed ID: 32340643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis Use Among Patients With Psychotic Disorders.
    Hirschtritt ME; Young-Wolff KC; Mathalon DH; Satre DD
    Perm J; 2021 May; 25():. PubMed ID: 35348056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study.
    Gerlach J; Koret B; Gereš N; Matić K; Prskalo-Čule D; Zadravec Vrbanc T; Lovretić V; Skopljak K; Matoš T; Šimunović Filipčić I; Filipčić I
    Psychiatr Danub; 2019 Jun; 31(Suppl 2):162-170. PubMed ID: 31158117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent contribution of polygenic risk for schizophrenia and cannabis use in predicting psychotic-like experiences in young adulthood: testing gene × environment moderation and mediation.
    Elkrief L; Lin B; Marchi M; Afzali MH; Banaschewski T; Bokde ALW; Quinlan EB; Desrivières S; Flor H; Garavan H; Gowland P; Heinz A; Ittermann B; Martinot JL; Martinot MP; Nees F; Orfanos DP; Paus T; Poustka L; Hohmann S; Fröhner JH; Smolka MN; Walter H; Whelan R; Schumann G; Luykx J; Boks MP; Conrod PJ;
    Psychol Med; 2023 Apr; 53(5):1759-1769. PubMed ID: 37310336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cannabis use on incidence of psychosis in people at clinical high risk.
    Chester LA; Valmaggia LR; Kempton MJ; Chesney E; Oliver D; Hedges EP; Klatsa E; Stahl D; van der Gaag M; de Haan L; Nelson B; McGorry P; Amminger GP; Riecher-Rössler A; Studerus E; Bressan R; Barrantes-Vidal N; Krebs MO; Glenthøj B; Nordentoft M; Ruhrmann S; Sachs G; McGuire P;
    Psychiatry Clin Neurosci; 2023 Sep; 77(9):469-477. PubMed ID: 37070555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis.
    D'Souza DC; DiForti M; Ganesh S; George TP; Hall W; Hjorthøj C; Howes O; Keshavan M; Murray RM; Nguyen TB; Pearlson GD; Ranganathan M; Selloni A; Solowij N; Spinazzola E
    World J Biol Psychiatry; 2022 Dec; 23(10):719-742. PubMed ID: 35315315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use and risk of psychosis: an etiological link?
    Verdoux H; Tournier M
    Epidemiol Psichiatr Soc; 2004; 13(2):113-9. PubMed ID: 15298320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    Br J Psychiatry; 2005 Dec; 187():510-5. PubMed ID: 16319402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis-related psychiatric disorders.
    Matsumoto T; Kawabata T; Okita K; Tanibuchi Y; Funada D; Murakami M; Usami T; Yokoyama R; Naruse N; Aikawa Y; Furukawa A; Komatsuzaki C; Hashimoto N; Fujita O; Umemoto A; Kagaya A; Shimane T
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):332-341. PubMed ID: 32896111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.